title: Multidrug-resistant Pseudomonas aeruginosa infection in neutropenic patients successfully treated with a combination of polymyxin B and rifampin.
authors.forename: M
authors.initials: M
authors.lastname: Ostronoff
authors.forename: F
authors.initials: F
authors.lastname: Ostronoff
authors.forename: A
authors.initials: A
authors.lastname: Sucupira
authors.forename: A P
authors.initials: AP
authors.lastname: Souto Maior
authors.forename: M
authors.initials: M
authors.lastname: Caniza
authors.forename: R
authors.initials: R
authors.lastname: Florêncio
authors.forename: M C
authors.initials: MC
authors.lastname: Domingues
authors.forename: R
authors.initials: R
authors.lastname: Calixto
authors.forename: K
authors.initials: K
authors.lastname: Matias
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002481:Cellulitis / Q000188:drug therapy / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009503:Neutropenia; D010689:Phlebitis / Q000188:drug therapy / Q000382:microbiology; D011112:Polymyxin B / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012293:Rifampin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D011112:Polymyxin B; D012293:Rifampin